{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:44:39Z","timestamp":1695570279401},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","award":["1R01HD065740-01A1"],"award-info":[{"award-number":["1R01HD065740-01A1"]}]},{"name":"University of Tennessee General Clinical Research Center (GCRC)"},{"DOI":"10.13039\/100006506","name":"Depomed, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006506","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.cct.2013.06.015","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T07:01:28Z","timestamp":1372489288000},"page":"154-165","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response"],"prefix":"10.1016","volume":"36","author":[{"given":"Candace S.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim Y.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie A.","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria A.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2013.06.015_bb0005","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0002-9378(91)91444-2","article-title":"Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population","volume":"164","author":"Goetsch","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0010","first-page":"772","article-title":"2003 ISSVD terminology and classification of vulvodynia: a historical perspective","volume":"49","author":"Moyal-Barraco","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0015","doi-asserted-by":"crossref","first-page":"128.e1","DOI":"10.1016\/j.ajog.2006.07.047","article-title":"Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study","volume":"196","author":"Arnold","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.AOG.0000199951.26822.27","article-title":"Vulvodynia: characteristics and associations with comorbidity and quality of life","volume":"107","author":"Arnold","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaad.2008.06.032","article-title":"Effects of vulvodynia on quality of life","volume":"60","author":"Ponte","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cct.2013.06.015_bb0030","first-page":"82","article-title":"A population-based assessment of chronic unexplained vulvar pain: Have we underestimated the prevalence of vulvodynia?","volume":"58","author":"Harlow","year":"2003","journal-title":"J Am Med Womens Assoc"},{"key":"10.1016\/j.cct.2013.06.015_bb0035","first-page":"679","article-title":"Clinical profile of vulvodynia patients: a prospective study of 300 patients","volume":"45","author":"Sadownik","year":"2000","journal-title":"J Reprod Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jwh.2007.0676","article-title":"Self-management, amitriptyline, and amitriptyline plus triamcinolone in the management of vulvodynia","volume":"18","author":"Brown","year":"2009","journal-title":"J Women's Health"},{"issue":"3","key":"10.1016\/j.cct.2013.06.015_bb0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/AOG.0b013e3181e9e0ab","article-title":"Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial","volume":"116","author":"Foster","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cct.2013.06.015_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00128360-200501000-00009","article-title":"The vulvodynia guideline","volume":"9","author":"Haefner","year":"2005","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.cct.2013.06.015_bb0055","first-page":"9","article-title":"Dysesthetic \u201cessential\u201d vulvodynia: treatment with amitriptyline","volume":"38","author":"McKay","year":"1993","journal-title":"J Reprod Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/01443610120085591","article-title":"Response to treatment in dysaesthetic vulvodynia","volume":"6","author":"Munday","year":"2001","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.cct.2013.06.015_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1479-828X.1999.tb03450.x","article-title":"Vulvar vestibulitis syndrome: an often unrecognized cause of dyspareunia","volume":"39","author":"Pagano","year":"1999","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.lgt.0000225899.75207.0a","article-title":"Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors","volume":"10","author":"Reed","year":"2006","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.cct.2013.06.015_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pain.2005.05.025","article-title":"Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women","volume":"117","author":"Foster","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajog.2003.09.060","article-title":"Primary and secondary vulvar vestibulitis syndrome: systemic pain perception and psychophysical characteristics","volume":"191","author":"Granot","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpain.2004.03.005","article-title":"Association between quantitative sensory testing, treatment choice, and subsequent pain reduction in vulvar vestibulitis syndrome","volume":"5","author":"Granot","year":"2004","journal-title":"J Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-1211(97)00084-3","article-title":"A summary of mechanistic hypotheses of gabapentin pharmacology","volume":"29","author":"Taylor","year":"1998","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.cct.2013.06.015_bb0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.ogx.0000219814.40759.38","article-title":"A conceptual model for the pathophysiology of vulvar vestibulitis syndrome","volume":"61","author":"Zolnoun","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.cct.2013.06.015_bb0100","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.22457","article-title":"Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"56","author":"Arnold","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cct.2013.06.015_bb0105","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of post herpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2013.06.015_bb0110","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2013.06.015_bb0115","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.diabres.2012.03.010","article-title":"A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy, tolerability in a double-blind, randomized, controlled clinical trial","volume":"97","author":"Sandercock","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10.1016\/j.cct.2013.06.015_bb0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11539520-000000000-00000","article-title":"Gabapentin extended-release tablets for the treatment of patients with post herpetic neuralgia: a randomized, double-blind, placebo-controlled, multicenter study","volume":"30","author":"Wallace","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.cct.2013.06.015_bb0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0135","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"For the EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cct.2013.06.015_bb0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"For the Canadian Pain Society. Pharmacological management of chronic neuropathic pain\u2014consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.cct.2013.06.015_bb0145","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1213\/00000539-199912000-00026","article-title":"Gabapentin therapy for vulvodynia","volume":"89","author":"Ben-David","year":"1999","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.cct.2013.06.015_bb0150","first-page":"103","article-title":"Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked","volume":"52","author":"Harris","year":"2007","journal-title":"Reprod Med"},{"issue":"3","key":"10.1016\/j.cct.2013.06.015_bb0155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/AOG.0b013e3181827c77","article-title":"Topical gabapentin in the treatment of localized and generalized vulvodynia","volume":"112","author":"Boardman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/OGX.0b013e3182277fb7","article-title":"Vulvodynia interventions: systematic review and evidence grading","volume":"66","author":"Andrews","year":"2011","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.cct.2013.06.015_bb0165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/j.1600-0412.2001.800709.x","article-title":"The expression of cyclooxygenase 2 and inducible nitric oxide synthase indicates no active inflammation in vulvar vestibulitis","volume":"80","author":"Bohm-Starke","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.cct.2013.06.015_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0304-3959(01)00442-0","article-title":"Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome","volume":"96","author":"Pukall","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pain.2005.02.020","article-title":"Neural correlates of painful genital touch in women with vulvar vestibulitis syndrome","volume":"115","author":"Pukall","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0180","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1743-6109.2009.01642.x","article-title":"Pelvic floor muscle assessment outcomes in women with and with provoked vestibulodynia and the impact of physical therapy","volume":"7","author":"Genitilcore-Saulnoier","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0185","first-page":"157","article-title":"Establishing the diagnosis of vulvar vestibulitis","volume":"42","author":"White","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/00926230590950208","article-title":"Psychological factors associated with perception of experimental pain in vulvar vestibulitis syndrome","volume":"31","author":"Granot","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.cct.2013.06.015_bb0195","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brat.2009.09.014","article-title":"Provoked vestibulodynia: psychological predictors of topical and cognitive-behavioral treatment outcome","volume":"48","author":"Deroschers","year":"2010","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.cct.2013.06.015_bb0200","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/AOG.0b013e31821c33dc","article-title":"Differences in primary compared with secondary vestibulodynia by immunohistochemistry","volume":"117","author":"Leclair","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0205","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ajog.2010.01.028","article-title":"Histologic and receptor analysis of primary and secondary vestibulodynia and controls: a prospective study","volume":"202","author":"Goetsch","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0210","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.pain.2012.12.019","article-title":"The role of circulating sex hormones in menstrual cycle-dependent modulation of pain-related brain activation","volume":"154","author":"Veldhuijzen","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0304-3959(98)00258-9","article-title":"A meta-analytic review of pain perception across the menstrual cycle","volume":"81","author":"Riley","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/aje\/kwf037","article-title":"Use of oral contraceptive pills and vulvar vestibulitis: a case\u2013control study","volume":"156","author":"Bouchard","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cct.2013.06.015_bb0225","first-page":"888","article-title":"Decreased mechanical pain threshold on the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis?","volume":"49","author":"Bohm-Starke","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0460","series-title":"Facilitating Scientific Advancement on Vulvodynia through the Development of Research Diagnostic Criteria","author":"Eunice Kennedy Shriver National Insti6tue of Child Health and Human Development (NICHD)","year":"2013"},{"key":"10.1016\/j.cct.2013.06.015_bb0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2010.02.018","article-title":"Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations","volume":"149","author":"Dworkin","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"and IMMPACT Consensus Group. Interpreting the clinical importance of treatment outcomes for chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0245","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.pain.2012.03.003","article-title":"Considerations for improving assay sensitivity in chronic pain trials: IMMPACT recommendations","volume":"153","author":"Dworkin","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.wnl.0000275528.01263.6c","article-title":"Clinical trial outcome in neuropathic pain: relationship to study characteristics","volume":"70","author":"Katz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cct.2013.06.015_bb0255","first-page":"110","article-title":"Vulvar vestibulitis syndrome","volume":"32","author":"Friedrich","year":"1987","journal-title":"J Reprod Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0029-7844(02)02080-X","article-title":"Vulvar disease","volume":"100","author":"Foster","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0265","unstructured":"Depomed, Inc. Menlo Park, CA 94025. Gralise\u00ae (gabapentin) tablet. Prescribing Information. Issued Aug 2012."},{"key":"10.1016\/j.cct.2013.06.015_bb0270","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0091270010368411","article-title":"Pharmacokinetics of gabapentin in a novel gastric retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food","volume":"51","author":"Chen","year":"2011","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.cct.2013.06.015_bb0275","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.clinthera.2008.05.008","volume":"30","author":"Gordi","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.cct.2013.06.015_bb0465","series-title":"19th Annual Meeting of the North American Menopause Society, Orlando, FL","article-title":"Positive efficacy data from a Phase 2 trial of gabapentin extended-release in the treatment of menopausal hot flashes","author":"Sweeney","year":"2008"},{"issue":"9","key":"10.1016\/j.cct.2013.06.015_bb0285","first-page":"593","article-title":"Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms","volume":"32","author":"Cowles","year":"2012","journal-title":"Clin Drug Investig"},{"issue":"2","key":"10.1016\/j.cct.2013.06.015_bb0470","first-page":"377","article-title":"A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome","volume":"24","author":"Okifuji","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cct.2013.06.015_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/AJP.0b013e318156db13","article-title":"Vaginal pressure-pain thresholds: initial validation and reliability assessment in healthy women","volume":"24","author":"Tu","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0300","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/AOG.0b013e31819bda7c","article-title":"The Tampon Test for vulvodynia research: reliability, construct validity, responsiveness","volume":"113","author":"Foster","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cct.2013.06.015_bb0305","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1752-8062.2009.00109.x","article-title":"Biomedical informatics unit (BMIU): Slim-prim system bridges the gap between laboratory discovery and practice","volume":"2","author":"Viangteeravat","year":"2009","journal-title":"Clin Transl Sci"},{"issue":"Suppl. 4","key":"10.1016\/j.cct.2013.06.015_bb0310","doi-asserted-by":"crossref","first-page":"P5","DOI":"10.1186\/1471-2105-11-S4-P5","article-title":"Slim-Prim: an integrated data system for clinical and translational research","volume":"11","author":"Viangteeravat","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cct.2013.06.015_bb0475","series-title":"Presented at the fourth meeting of the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials IMPACT-IV","article-title":"The Brief Pain Inventory: meaningful changes in pain interference","author":"Cleeland","year":"2004"},{"key":"10.1016\/j.cct.2013.06.015_bb0320","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.cct.2013.06.015_bb0325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-244X-5-46","article-title":"The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice","volume":"5","author":"Olsson","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.cct.2013.06.015_bb0480","series-title":"ECDEU assessment manual for psychopharmacology (DHEW Publication No. ADM 76-338)","author":"Guy","year":"1976"},{"key":"10.1016\/j.cct.2013.06.015_bb0335","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a Multidimensional Self-Report Instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.cct.2013.06.015_bb0485","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2307\/348022","article-title":"Short Marital-Adjustment and Prediction Tests: their reliability and validity","author":"Locke","year":"1959","journal-title":"Marriage Fam Living"},{"key":"10.1016\/j.cct.2013.06.015_bb0490","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36)","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.cct.2013.06.015_bb0350","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/08964289.1995.9933752","article-title":"The reliability and validity of a sexual and physical abuse history questionnaire in female patients with gastrointestinal disorders","volume":"21","author":"Leserman","year":"1995","journal-title":"Behav Med"},{"key":"10.1016\/j.cct.2013.06.015_bb0360","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0304-3959(89)90079-1","article-title":"Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin","volume":"38","author":"Simone","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0495","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/brain\/112.5.1317","article-title":"Heat and mechanical hyperalgesia induced by capsaicin. Cross modality threshold modulation in human C nociceptors","volume":"112","author":"Culp","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.cct.2013.06.015_bb0370","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1113\/jphysiol.1992.sp019068","article-title":"Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin","volume":"448","author":"LaMotte","year":"1992","journal-title":"J Physiol"},{"key":"10.1016\/j.cct.2013.06.015_bb0375","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3959(00)00311-0","article-title":"Capsaicin evoked pain and allodynia in post-herpetic neurolgia","volume":"88","author":"Petersen","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0380","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.pain.2011.06.001","article-title":"Sensory responses to injection and punctate application of capsaicin and histamine to the skin","volume":"152","author":"Sikand","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0385","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.biopsycho.2007.10.004","article-title":"Heart rate variability and pain: association of two interrelated homeostatic processes","volume":"77","author":"Appelhaus","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.cct.2013.06.015_bb0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0029-7844(01)01389-8","article-title":"Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria","volume":"98","author":"Bergeron","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0002-9378(99)70442-4","article-title":"Assessment of response to treatment in vulvar vestibulitis syndrome by means of the vulvar algesiometer","volume":"181","author":"Eva","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0500","series-title":"Medscape. FDA Puts 16 drugs on Watch List","author":"Lowes","year":"2012"},{"key":"10.1016\/j.cct.2013.06.015_bb0505","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force","volume":"97","author":"McKenney","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cct.2013.06.015_bb0410","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1056\/NEJMe030054","article-title":"Interpreting incomplete data in studies of diet and weight loss","volume":"348","author":"Ware","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cct.2013.06.015_bb0510","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cct.2013.06.015_bb0420","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/AOG.0b013e318180965b","article-title":"Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study","volume":"112","author":"Reed","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cct.2013.06.015_bb0425","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The Pain Catastrophizing Scale: development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol Assess"},{"key":"10.1016\/j.cct.2013.06.015_bb0430","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3959(83)90125-2","article-title":"The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment","volume":"17","author":"Rosenstiel","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0435","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","article-title":"Core outcome domains for chronic pain clinical trials: IMMPACT recommendations","volume":"106","author":"Turk","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.cct.2013.06.015_bb0440","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cct.2013.06.015_bb0445","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007691-200308000-00007","article-title":"Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study","volume":"25","author":"Lindberger","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cct.2013.06.015_bb0450","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomized controlled trials: \u201cto whom do the results of this trial apply?\u201d","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2013.06.015_bb0455","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2007.06.014","article-title":"Steroid receptor expression in the vulvar vestibular mucosa effects of oral contraceptives and menstrual cycle","volume":"76","author":"Johannesson","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.cct.2013.06.015_bb0515","first-page":"14","article-title":"Vulvodynia and menopause","author":"Bachmann","year":"2006","journal-title":"Menopause Manag"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714413001079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714413001079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T20:10:18Z","timestamp":1645906218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714413001079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1551714413001079"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2013.06.015","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2013.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}